$FHI
FEDERATED HERMES, INC. Stock $fhi

$fhi Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000105628819000010 Filed on May 01, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$307.1M	$263.9M
YoY Change	16.37%	-3.53%
Cost Of Revenue	$10.50M	$9.600M
YoY Change	9.38%	43.28%
Gross Profit	$296.6M	$254.2M
YoY Change	16.68%	-4.72%
Gross Profit Margin	96.6%	96.34%
Selling, General & Admin	$221.0M	$172.9M
YoY Change	27.82%	-6.64%
% of Gross Profit	74.51%	68.02%
Research & Development	$12.79M	$8.433M
YoY Change	51.71%	2.53%
% of Gross Profit	4.31%	3.32%
Depreciation & Amortization	$7.200M	$2.600M
YoY Change	176.92%	0.0%
% of Gross Profit	2.43%	1.02%
Operating Expenses	$236.2M	$184.2M
YoY Change	28.22%	-5.9%
Operating Profit	$70.89M	$79.67M
YoY Change	-11.02%	2.44%
Interest Expense	$1.300M	-$600.0K
YoY Change	-316.67%	-119.35%
% of Operating Profit	1.83%	-0.75%
Other Income/Expense, Net	$1.633M	-$755.0K
YoY Change	-316.29%	-124.26%
Pretax Income	$72.52M	$78.92M
YoY Change	-8.1%	-2.43%
Income Tax	$17.91M	$18.91M
% Of Pretax Income	24.7%	23.96%
Net Earnings	$54.55M	$60.33M
YoY Change	-9.59%	21.53%
Net Earnings / Revenue	17.76%	22.87%
Basic Earnings Per Share
Diluted Earnings Per Share	$561.9K	$620.4K
COMMON SHARES
Basic Shares Outstanding	96.99M shares	97.19M shares
Diluted Shares Outstanding	97.00M shares	97.19M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$162.1M	$377.6M
YoY Change	-57.07%	35.97%
Cash & Equivalents	$134.5M	$325.6M
Short-Term Investments	$27.60M	$51.90M
Other Short-Term Assets	$2.263M	$1.996M
YoY Change	13.38%	-11.25%
Inventory
Prepaid Expenses	$17.18M	$11.40M
Receivables	$48.71M	$50.06M
Other Receivables	$48.10M	$0.00
Total Short-Term Assets	$278.4M	$441.0M
YoY Change	-36.88%	31.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$53.98M	$38.70M
YoY Change	39.49%	-0.1%
Goodwill	$813.9M	$660.0M
YoY Change	23.31%	0.0%
Intangibles	$342.9M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$36.87M	$18.84M
YoY Change	95.65%	-13.0%
Total Long-Term Assets	$1.357B	$794.3M
YoY Change	70.82%	-0.43%
TOTAL ASSETS
Total Short-Term Assets	$278.4M	$441.0M
Total Long-Term Assets	$1.357B	$794.3M
Total Assets	$1.635B	$1.235B
YoY Change	32.37%	9.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$61.40M	$54.20M
YoY Change	13.28%	11.07%
Accrued Expenses	$54.30M	$27.10M
YoY Change	100.37%	8.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$131.7M	$99.64M
YoY Change	32.17%	-21.9%
LONG-TERM LIABILITIES
Long-Term Debt	$130.0M	$165.0M
YoY Change	-21.21%	3.51%
Other Long-Term Liabilities	$19.13M	$20.58M
YoY Change	-7.03%	0.86%
Total Long-Term Liabilities	$419.5M	$307.4M
YoY Change	36.47%	-15.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$131.7M	$99.64M
Total Long-Term Liabilities	$419.5M	$307.4M
Total Liabilities	$551.2M	$407.1M
YoY Change	35.42%	-16.98%
SHAREHOLDERS EQUITY
Retained Earnings	$807.3M	$721.8M
YoY Change	11.84%	33.62%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$897.7M	$799.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.635B	$1.235B
YoY Change	32.37%	9.01%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$54.55M	$60.33M
YoY Change	-9.59%	21.53%
Depreciation, Depletion And Amortization	$7.200M	$2.600M
YoY Change	176.92%	0.0%
Cash From Operating Activities	$16.76M	$48.10M
YoY Change	-65.16%	44.78%
INVESTING ACTIVITIES
Capital Expenditures	$5.060M	$3.106M
YoY Change	62.91%	45.62%
Acquisitions	$0.00	$0.00
YoY Change		-100.0%
Other Investing Activities	-$400.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$5.441M	-$3.089M
YoY Change	76.14%	-160.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.485M	$4.024M
YoY Change	-63.1%	-72.94%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$35.92M	-$35.60M
YoY Change	0.9%	-26.67%
NET CHANGE
Cash From Operating Activities	$16.76M	$48.10M
Cash From Investing Activities	-$5.441M	-$3.089M
Cash From Financing Activities	-$35.92M	-$35.60M
Net Change In Cash	-$22.34M	$9.407M
YoY Change	-337.46%	-192.16%
FREE CASH FLOW
Cash From Operating Activities	$16.76M	$48.10M
Capital Expenditures	$5.060M	$3.106M
Free Cash Flow	$11.70M	$44.99M
YoY Change	-74.0%	44.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001056288
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	FEDERATED INVESTORS INC /PA/
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	dei	Trading Symbol TradingSymbol	FII
CY2018Q1	fii	Comprehensive Income Net Of Tax Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToRedeemableNoncontrollingInterest	-325000	USD
CY2019Q1	fii	Comprehensive Income Net Of Tax Attributable To Redeemable Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToRedeemableNoncontrollingInterest	3779000	USD
CY2018Q1	fii	Equity Profit Loss EquityProfitLoss	60331000	USD
CY2019Q1	fii	Equity Profit Loss EquityProfitLoss	54546000	USD
CY2018Q1	fii	Fee Waivers FeeWaivers	87400000	USD
CY2019Q1	fii	Fee Waivers FeeWaivers	98800000	USD
CY2018Q4	fii	Investments Affiliates And Other InvestmentsAffiliatesAndOther	10860000	USD
CY2019Q1	fii	Investments Affiliates And Other InvestmentsAffiliatesAndOther	12033000	USD
CY2018Q4	fii	Investments Consolidated Investment Companies InvestmentsConsolidatedInvestmentCompanies	22798000	USD
CY2019Q1	fii	Investments Consolidated Investment Companies InvestmentsConsolidatedInvestmentCompanies	15593000	USD
CY2017Q2	fii	Line Of Credit Facility Accordion Feature LineOfCreditFacilityAccordionFeature	200000000	USD
CY2019Q1	fii	Liquidation Of Investments Consolidated Investment Companies LiquidationOfInvestmentsConsolidatedInvestmentCompanies	6200000	USD
CY2017Q2	fii	Number Of Banks As Lenders NumberOfBanksAsLenders	10	bank
CY2019Q1	fii	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	3315000	USD
CY2018Q1	fii	Other Comprehensive Income Loss Net Of Tax Statement Of Shareholders Equity OtherComprehensiveIncomeLossNetOfTaxStatementOfShareholdersEquity	277000	USD
CY2019Q1	fii	Other Comprehensive Income Loss Net Of Tax Statement Of Shareholders Equity OtherComprehensiveIncomeLossNetOfTaxStatementOfShareholdersEquity	7664000	USD
CY2018Q1	fii	Proceedsfrom Paymentsfor Investments Consolidatedinvestmentcompanies ProceedsfromPaymentsforInvestmentsConsolidatedinvestmentcompanies	500000	USD
CY2019Q1	fii	Proceedsfrom Paymentsfor Investments Consolidatedinvestmentcompanies ProceedsfromPaymentsforInvestmentsConsolidatedinvestmentcompanies	8136000	USD
CY2018Q1	fii	Proceedsfromredemptionsofinvestmentsaffiliatesother Proceedsfromredemptionsofinvestmentsaffiliatesother	1572000	USD
CY2019Q1	fii	Proceedsfromredemptionsofinvestmentsaffiliatesother Proceedsfromredemptionsofinvestmentsaffiliatesother	1185000	USD
CY2018Q1	fii	Purchasesofinvestments Affiliatesandother PurchasesofinvestmentsAffiliatesandother	1555000	USD
CY2019Q1	fii	Purchasesofinvestments Affiliatesandother PurchasesofinvestmentsAffiliatesandother	1566000	USD
CY2018Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	56110000	USD
CY2019Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	61381000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	60094000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48708000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	89937000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	89356000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14617000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6953000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	50000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	191000	USD
CY2018Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	839000	USD
CY2019Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	592000	USD
CY2018Q4	us-gaap	Assets Assets	1543683000	USD
CY2019Q1	us-gaap	Assets Assets	1635176000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	304101000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	278351000	USD
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1239582000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	325609000	USD
CY2019Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1356825000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	156832000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	134485000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	316809000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326216000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157426000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	135088000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9407000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-22338000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.27
CY2018Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	8433000	USD
CY2019Q1	us-gaap	Communications And Information Technology CommunicationsAndInformationTechnology	12794000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	60354000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62210000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	60029000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	65989000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-129000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4318000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4696000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	148164000	USD
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	153603000	USD
CY2018Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2638000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7221000	USD
CY2018Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	25265000	USD
CY2019Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	27217000	USD
CY2018Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	34985000	USD
CY2019Q1	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	48092000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.60
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.54
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2264000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	113865000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	40781000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11203000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14240000	USD
CY2018Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	723000	USD
CY2019Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-492000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	809608000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	813920000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78916000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	72522000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18910000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17911000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-43666000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-72337000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	11070000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	6281000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-818000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2693000	USD
CY2018Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3424000	USD
CY2019Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	575000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	339639000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	342889000	USD
CY2018Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1330000	USD
CY2019Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1400000	USD
CY2018Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1900000	USD
CY2019Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1030000	USD
CY2018Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	78374000	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	111216000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	155700000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	70200000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	18400000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	18200000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	17500000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	17900000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	13500000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	25400000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	504049000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	551237000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1543683000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1635176000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	181180000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	131692000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	322869000	USD
CY2019Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	419545000	USD
CY2018Q4	us-gaap	Line Of Credit LineOfCredit	135000000	USD
CY2019Q1	us-gaap	Line Of Credit LineOfCredit	130000000	USD
CY2018Q4	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.03474
CY2019Q1	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.03614
CY2017Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	375000000	USD
CY2019Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	245000000	USD
CY2019Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.00125
CY2018Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1182000	USD
CY2019Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1679000	USD
CY2018Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3228000	USD
CY2019Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	4190000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35600000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35919000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3089000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16758000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5441000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48096000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	60331000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	54546000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-325000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	65000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	57956000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	52411000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	57956000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	52378000	USD
CY2018Q1	us-gaap	Noninterest Expense Distribution And Servicing Fees NoninterestExpenseDistributionAndServicingFees	72498000	USD
CY2019Q1	us-gaap	Noninterest Expense Distribution And Servicing Fees NoninterestExpenseDistributionAndServicingFees	77632000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-755000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1633000	USD
CY2018Q1	us-gaap	Occupancy Net OccupancyNet	7541000	USD
CY2019Q1	us-gaap	Occupancy Net OccupancyNet	11362000	USD
CY2018Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	243000	USD
CY2019Q1	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	7664000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	184181000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	236161000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	79671000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	70889000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	4400000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	130300000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13502000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	116813000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4700000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	109167000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0379
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y2M13D
CY2018Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	3300000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2019000	USD
CY2019Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2263000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	37106000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	36869000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	243000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	7664000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	191000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	23000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	11378000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	23000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7664000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	29000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	USD
CY2018Q1	us-gaap	Other Expenses OtherExpenses	1655000	USD
CY2019Q1	us-gaap	Other Expenses OtherExpenses	4633000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11205000	USD
CY2019Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16028000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	39705000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19129000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-143000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	324000	USD
CY2018Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	2375000	USD
CY2019Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	2135000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4024000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1485000	USD
CY2018Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	25265000	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	27217000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3106000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5060000	USD
CY2018Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1684000	USD
CY2019Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2260000	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16513000	USD
CY2019Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17177000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	101000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2018Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2019Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	8800000	USD
CY2018Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	500000	USD
CY2019Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	43000	USD
CY2018Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-228000	USD
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2018Q1	us-gaap	Professional Fees ProfessionalFees	9631000	USD
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	10486000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	60006000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	54611000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53229000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53980000	USD
CY2018Q1	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	322000	USD
CY2018Q1	us-gaap	Reclassification From Aoci Current Period Tax ReclassificationFromAociCurrentPeriodTax	102000	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	182513000	USD
CY2019Q1	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	186200000	USD
CY2018Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	5000000	USD
CY2019Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	13800000	USD
CY2018Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	607000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	603000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	791823000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	807322000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	263852000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	307050000	USD
CY2019Q1	us-gaap	Revenue Performance Obligation Description Of Timing RevenuePerformanceObligationDescriptionOfTiming	Generally, contracts are billed in arrears on a quarterly basis and have a three year duration, after which the customer can terminate the agreement with a three to twelve month notice.
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	12641000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	6892000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3463000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1746000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	540000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6967000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7110000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	899269	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	498324	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7067000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7110000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	761215000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	799620000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	857121000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	897739000	USD
CY2018Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	0	USD
CY2019Q1	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	3714000	USD
CY2018Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	2821000	USD
CY2019Q1	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	3848000	USD
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8702074	shares
CY2019Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8264583	shares
CY2018Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	287337000	USD
CY2019Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	276992000	USD
CY2018Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3876000	USD
CY2019Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1485000	USD
CY2018Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	USD
CY2019Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	33000	USD
CY2018Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1905000	USD
CY2019Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2162000	USD
CY2018Q4	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets And Liabilities Net VariableInterestEntityConsolidatedCarryingAmountAssetsAndLiabilitiesNet	10100000	USD
CY2019Q1	us-gaap	Variable Interest Entity Consolidated Carrying Amount Assets And Liabilities Net VariableInterestEntityConsolidatedCarryingAmountAssetsAndLiabilitiesNet	4200000	USD
CY2018Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000	shares
CY2019Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97189000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96995000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97187000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96994000	shares
CY2019Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;"></font><font style="font-family:inherit;font-size:12pt;color:#000000;font-style:italic;text-decoration:none;">Basis of Presentation</font><font style="font-family:inherit;font-size:12pt;font-style:italic;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federated Investors, Inc. and its consolidated subsidiaries, including Hermes Fund Managers Limited (</font><font style="font-family:inherit;font-size:10pt;">Hermes</font><font style="font-family:inherit;font-size:10pt;">) beginning </font><font style="font-family:inherit;font-size:10pt;">July 1, 2018</font><font style="font-family:inherit;font-size:10pt;">, (collectively, </font><font style="font-family:inherit;font-size:10pt;">Federated</font><font style="font-family:inherit;font-size:10pt;">) provides investment advisory, administrative, distribution and other services to various investment products, including sponsored investment companies and other funds (</font><font style="font-family:inherit;font-size:10pt;">Federated Funds</font><font style="font-family:inherit;font-size:10pt;">) and </font><font style="font-family:inherit;font-size:10pt;">Separate Accounts</font><font style="font-family:inherit;font-size:10pt;"> (which include separately managed accounts, institutional accounts, sub-advised funds and other managed products) in both domestic and international markets, as well as </font><font style="font-family:inherit;font-size:10pt;">stewardship services</font><font style="font-family:inherit;font-size:10pt;"> to various companies. The interim Consolidated Financial Statements of </font><font style="font-family:inherit;font-size:10pt;">Federated</font><font style="font-family:inherit;font-size:10pt;"> included herein have been prepared in accordance with </font><font style="font-family:inherit;font-size:10pt;">U.S.</font><font style="font-family:inherit;font-size:10pt;"> generally accepted accounting principles (</font><font style="font-family:inherit;font-size:10pt;">GAAP</font><font style="font-family:inherit;font-size:10pt;">). In the opinion of management, the financial statements reflect all adjustments that are of a normal recurring nature and necessary for a fair presentation of the results for the interim periods presented.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In preparing the financial statements, management is required to make estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates, and such differences may be material to the Consolidated Financial Statements. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These financial statements should be read in conjunction with Federated's Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2018</font><font style="font-family:inherit;font-size:10pt;">. Certain items previously reported have been reclassified to conform to the current period's presentation.</font></div></div>

Files In Submission

Name	View Source	Status
0001056288-19-000010-index-headers.html	Edgar Link	pending
0001056288-19-000010-index.html	Edgar Link	pending
0001056288-19-000010.txt	Edgar Link	pending
0001056288-19-000010-xbrl.zip	Edgar Link	pending
exhibit1010hsbcisda8tham.htm	Edgar Link	pending
exhibit1010hsbcisda8tham001.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham002.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham003.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham004.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham005.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham006.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham007.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham008.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham009.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham010.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham011.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham012.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham013.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham014.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham015.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham016.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham017.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham018.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham019.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham020.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham021.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham022.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham023.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham024.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham025.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham026.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham027.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham028.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham029.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham030.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham031.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham032.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham033.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham034.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham035.jpg	Edgar Link	pending
exhibit1010hsbcisda8tham036.jpg	Edgar Link	pending
exhibit1011hsbcisda9tham.htm	Edgar Link	pending
exhibit1011hsbcisda9tham001.jpg	Edgar Link	pending
exhibit1011hsbcisda9tham002.jpg	Edgar Link	pending
exhibit1011hsbcisda9tham003.jpg	Edgar Link	pending
exhibit1011hsbcisda9tham004.jpg	Edgar Link	pending
exhibit1011hsbcisda9tham005.jpg	Edgar Link	pending
exhibit10120080109hsbchi.htm	Edgar Link	pending
exhibit10120080109hsbchi001.jpg	Edgar Link	pending
exhibit10120080109hsbchi002.jpg	Edgar Link	pending
exhibit10120080109hsbchi003.jpg	Edgar Link	pending
exhibit10120080109hsbchi004.jpg	Edgar Link	pending
exhibit10120080109hsbchi005.jpg	Edgar Link	pending
exhibit10120080109hsbchi006.jpg	Edgar Link	pending
exhibit10120080109hsbchi007.jpg	Edgar Link	pending
exhibit10120080109hsbchi008.jpg	Edgar Link	pending
exhibit10120080109hsbchi009.jpg	Edgar Link	pending
exhibit10120080109hsbchi010.jpg	Edgar Link	pending
exhibit10120080109hsbchi011.jpg	Edgar Link	pending
exhibit10120080109hsbchi012.jpg	Edgar Link	pending
exhibit10120080109hsbchi013.jpg	Edgar Link	pending
exhibit10120080109hsbchi014.jpg	Edgar Link	pending
exhibit10120080109hsbchi015.jpg	Edgar Link	pending
exhibit10120080109hsbchi016.jpg	Edgar Link	pending
exhibit10120080109hsbchi017.jpg	Edgar Link	pending
exhibit10120080109hsbchi018.jpg	Edgar Link	pending
exhibit10120080109hsbchi019.jpg	Edgar Link	pending
exhibit10120080109hsbchi020.jpg	Edgar Link	pending
exhibit10120080109hsbchi021.jpg	Edgar Link	pending
exhibit10120080109hsbchi022.jpg	Edgar Link	pending
exhibit10120080109hsbchi023.jpg	Edgar Link	pending
exhibit10120080109hsbchi024.jpg	Edgar Link	pending
exhibit10120080109hsbchi025.jpg	Edgar Link	pending
exhibit10120080109hsbchi026.jpg	Edgar Link	pending
exhibit10120080109hsbchi027.jpg	Edgar Link	pending
exhibit10120080109hsbchi028.jpg	Edgar Link	pending
exhibit10120080109hsbchi029.jpg	Edgar Link	pending
exhibit10122013011710tha.htm	Edgar Link	pending
exhibit10122013011710tha001.jpg	Edgar Link	pending
exhibit10122013011710tha002.jpg	Edgar Link	pending
exhibit10122013011710tha003.jpg	Edgar Link	pending
exhibit10122013011710tha004.jpg	Edgar Link	pending
exhibit10132014050111tha.htm	Edgar Link	pending
exhibit10132014050111tha001.jpg	Edgar Link	pending
exhibit10132014050111tha002.jpg	Edgar Link	pending
exhibit10132014050111tha003.jpg	Edgar Link	pending
exhibit10132014050111tha004.jpg	Edgar Link	pending
exhibit10132014050111tha005.jpg	Edgar Link	pending
exhibit10132014050111tha006.jpg	Edgar Link	pending
exhibit1014hsbcisda12thi.htm	Edgar Link	pending
exhibit1014hsbcisda12thi001.jpg	Edgar Link	pending
exhibit1014hsbcisda12thi002.jpg	Edgar Link	pending
exhibit1014hsbcisda12thi003.jpg	Edgar Link	pending
exhibit1014hsbcisda12thi004.jpg	Edgar Link	pending
exhibit1015hsbcisda13tha.htm	Edgar Link	pending
exhibit1015hsbcisda13tha001.jpg	Edgar Link	pending
exhibit1015hsbcisda13tha002.jpg	Edgar Link	pending
exhibit1015hsbcisda13tha003.jpg	Edgar Link	pending
exhibit1015hsbcisda13tha004.jpg	Edgar Link	pending
exhibit1015hsbcisda13tha005.jpg	Edgar Link	pending
exhibit1015hsbcisda13tha006.jpg	Edgar Link	pending
exhibit1016hsbcisda14tha.htm	Edgar Link	pending
exhibit1016hsbcisda14tha001.jpg	Edgar Link	pending
exhibit1016hsbcisda14tha002.jpg	Edgar Link	pending
exhibit1016hsbcisda14tha003.jpg	Edgar Link	pending
exhibit1016hsbcisda14tha004.jpg	Edgar Link	pending
exhibit10172016041215tha.htm	Edgar Link	pending
exhibit10172016041215tha001.jpg	Edgar Link	pending
exhibit10172016041215tha002.jpg	Edgar Link	pending
exhibit10172016041215tha003.jpg	Edgar Link	pending
exhibit10172016041215tha004.jpg	Edgar Link	pending
exhibit10182016090716tha.htm	Edgar Link	pending
exhibit10182016090716tha001.jpg	Edgar Link	pending
exhibit10182016090716tha002.jpg	Edgar Link	pending
exhibit10182016090716tha003.jpg	Edgar Link	pending
exhibit10182016090716tha004.jpg	Edgar Link	pending
exhibit10182016090716tha005.jpg	Edgar Link	pending
exhibit10182016090716tha006.jpg	Edgar Link	pending
exhibit10192016092017tha.htm	Edgar Link	pending
exhibit10192016092017tha001.jpg	Edgar Link	pending
exhibit10192016092017tha002.jpg	Edgar Link	pending
exhibit10192016092017tha003.jpg	Edgar Link	pending
exhibit10192016092017tha004.jpg	Edgar Link	pending
exhibit10192016092017tha005.jpg	Edgar Link	pending
exhibit10192016092017tha006.jpg	Edgar Link	pending
exhibit10202016122118tha.htm	Edgar Link	pending
exhibit10202016122118tha001.jpg	Edgar Link	pending
exhibit10202016122118tha002.jpg	Edgar Link	pending
exhibit10202016122118tha003.jpg	Edgar Link	pending
exhibit10202016122118tha004.jpg	Edgar Link	pending
exhibit1021himlvhsbc19th.htm	Edgar Link	pending
exhibit1021himlvhsbc19th001.jpg	Edgar Link	pending
exhibit1021himlvhsbc19th002.jpg	Edgar Link	pending
exhibit1021himlvhsbc19th003.jpg	Edgar Link	pending
exhibit1021himlvhsbc19th004.jpg	Edgar Link	pending
exhibit1021himlvhsbc19th005.jpg	Edgar Link	pending
exhibit1021himlvhsbc19th006.jpg	Edgar Link	pending
exhibit1022hsbc20thamend.htm	Edgar Link	pending
exhibit1022hsbc20thamend001.jpg	Edgar Link	pending
exhibit1022hsbc20thamend002.jpg	Edgar Link	pending
exhibit1022hsbc20thamend003.jpg	Edgar Link	pending
exhibit1022hsbc20thamend004.jpg	Edgar Link	pending
exhibit1022hsbc20thamend005.jpg	Edgar Link	pending
exhibit1022hsbc20thamend006.jpg	Edgar Link	pending
exhibit1022hsbc20thamend007.jpg	Edgar Link	pending
exhibit1022hsbc20thamend008.jpg	Edgar Link	pending
exhibit1023-formofhermeslo.htm	Edgar Link	pending
exhibit1024-employmentcont.htm	Edgar Link	pending
exhibit1025-hermesfundmana.htm	Edgar Link	pending
exhibit1026coinvestments.htm	Edgar Link	pending
exhibit1026coinvestments001.jpg	Edgar Link	pending
exhibit1026coinvestments002.jpg	Edgar Link	pending
exhibit1026coinvestments003.jpg	Edgar Link	pending
exhibit1026coinvestments004.jpg	Edgar Link	pending
exhibit1026coinvestments005.jpg	Edgar Link	pending
exhibit1026coinvestments006.jpg	Edgar Link	pending
exhibit1026coinvestments007.jpg	Edgar Link	pending
exhibit1026coinvestments008.jpg	Edgar Link	pending
exhibit1026coinvestments009.jpg	Edgar Link	pending
exhibit1026coinvestments010.jpg	Edgar Link	pending
exhibit1026coinvestments011.jpg	Edgar Link	pending
exhibit1026coinvestments012.jpg	Edgar Link	pending
exhibit1026coinvestments013.jpg	Edgar Link	pending
exhibit1026coinvestments014.jpg	Edgar Link	pending
exhibit1026coinvestments015.jpg	Edgar Link	pending
exhibit1026coinvestments016.jpg	Edgar Link	pending
exhibit1026coinvestments017.jpg	Edgar Link	pending
exhibit1026coinvestments018.jpg	Edgar Link	pending
exhibit1026coinvestments019.jpg	Edgar Link	pending
exhibit1026coinvestments020.jpg	Edgar Link	pending
exhibit1026coinvestments021.jpg	Edgar Link	pending
exhibit1026coinvestments022.jpg	Edgar Link	pending
exhibit1026coinvestments023.jpg	Edgar Link	pending
exhibit1026coinvestments024.jpg	Edgar Link	pending
exhibit1026coinvestments025.jpg	Edgar Link	pending
exhibit1026coinvestments026.jpg	Edgar Link	pending
exhibit1026coinvestments027.jpg	Edgar Link	pending
exhibit1026coinvestments028.jpg	Edgar Link	pending
exhibit1026coinvestments029.jpg	Edgar Link	pending
exhibit1026coinvestments030.jpg	Edgar Link	pending
exhibit1026coinvestments031.jpg	Edgar Link	pending
exhibit1026coinvestments032.jpg	Edgar Link	pending
exhibit1026coinvestments033.jpg	Edgar Link	pending
exhibit1026coinvestments034.jpg	Edgar Link	pending
exhibit1026coinvestments035.jpg	Edgar Link	pending
exhibit1026coinvestments036.jpg	Edgar Link	pending
exhibit1026coinvestments037.jpg	Edgar Link	pending
exhibit1026coinvestments038.jpg	Edgar Link	pending
exhibit1026coinvestments039.jpg	Edgar Link	pending
exhibit1026coinvestments040.jpg	Edgar Link	pending
exhibit1026coinvestments041.jpg	Edgar Link	pending
exhibit1026coinvestments042.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090.htm	Edgar Link	pending
exhibit102hsbcisdacsa090001.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090002.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090003.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090004.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090005.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090006.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090007.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090008.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090009.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090010.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090011.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090012.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090013.jpg	Edgar Link	pending
exhibit102hsbcisdacsa090014.jpg	Edgar Link	pending
exhibit103hsbcisda1stame.htm	Edgar Link	pending
exhibit103hsbcisda1stame001.jpg	Edgar Link	pending
exhibit103hsbcisda1stame002.jpg	Edgar Link	pending
exhibit104hsbcisda2ndame.htm	Edgar Link	pending
exhibit104hsbcisda2ndame001.jpg	Edgar Link	pending
exhibit104hsbcisda2ndame002.jpg	Edgar Link	pending
exhibit104hsbcisda2ndame003.jpg	Edgar Link	pending
exhibit105hsbcisda3rdame.htm	Edgar Link	pending
exhibit105hsbcisda3rdame001.jpg	Edgar Link	pending
exhibit105hsbcisda3rdame002.jpg	Edgar Link	pending
exhibit105hsbcisda3rdame003.jpg	Edgar Link	pending
exhibit105hsbcisda3rdame004.jpg	Edgar Link	pending
exhibit106hsbcisda4thame.htm	Edgar Link	pending
exhibit106hsbcisda4thame001.jpg	Edgar Link	pending
exhibit106hsbcisda4thame002.jpg	Edgar Link	pending
exhibit106hsbcisda4thame003.jpg	Edgar Link	pending
exhibit107hsbcisda5thame.htm	Edgar Link	pending
exhibit107hsbcisda5thame001.jpg	Edgar Link	pending
exhibit107hsbcisda5thame002.jpg	Edgar Link	pending
exhibit107hsbcisda5thame003.jpg	Edgar Link	pending
exhibit107hsbcisda5thame004.jpg	Edgar Link	pending
exhibit108hsbcisda6thame.htm	Edgar Link	pending
exhibit108hsbcisda6thame001.jpg	Edgar Link	pending
exhibit108hsbcisda6thame002.jpg	Edgar Link	pending
exhibit108hsbcisda6thame003.jpg	Edgar Link	pending
exhibit108hsbcisda6thame004.jpg	Edgar Link	pending
exhibit108hsbcisda6thame005.jpg	Edgar Link	pending
exhibit108hsbcisda6thame006.jpg	Edgar Link	pending
exhibit108hsbcisda6thame007.jpg	Edgar Link	pending
exhibit108hsbcisda6thame008.jpg	Edgar Link	pending
exhibit109hsbccsa7thamen.htm	Edgar Link	pending
exhibit109hsbccsa7thamen001.jpg	Edgar Link	pending
exhibit109hsbccsa7thamen002.jpg	Edgar Link	pending
exhibit311-20190331.htm	Edgar Link	pending
exhibit312-20190331.htm	Edgar Link	pending
exhibit32-20190331.htm	Edgar Link	pending
fii-20190331.xml	Edgar Link	completed
fii-20190331.xsd	Edgar Link	pending
fii-20190331x10q.htm	Edgar Link	pending
fii-20190331_cal.xml	Edgar Link	unprocessable
fii-20190331_def.xml	Edgar Link	unprocessable
fii-20190331_lab.xml	Edgar Link	unprocessable
fii-20190331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FHI
FEDERATED HERMES, INC. Stock $fhi

2019 Q1 Form 10-Q Financial Statement

#000105628819000010 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FHI FEDERATED HERMES, INC. Stock $fhi

2019 Q1 Form 10-Q Financial Statement

#000105628819000010 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FHI
FEDERATED HERMES, INC. Stock $fhi